• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

AMO unveils WhiteStar Signature phaco system with advanced fluidic technology

Article

Advanced Medical Optics Inc. (AMO) announces the launch of the WhiteStar Signature phacoemulsification system with Fusion fluidics.

Advanced Medical Optics Inc. (AMO) announces the launch of the WhiteStar Signature phacoemulsification system with Fusion fluidics.

The advanced technology combines the performance of AMO's WhiteStar system with the safety of a revolutionary dual-pump fluidic system, according to the company. A streamlined user interface and easy-to-use accessories enhance efficiency of the operating room environment.

"The WhiteStar Signature system combines the efficiency and safety of WhiteStar phaco technology with improved fluidics that enhance chamber stability," said David Chang, MD, clinical professor of ophthalmology, University of California, San Francisco. "The dual pump represents the next generation in phaco fluidics, and the new user interface is a significant improvement for surgeons and staff."

The new fluidics technology provides chamber stability and effectively reduces post-occlusion surge by a significant margin, according to the company. The dual pump responsiveness has the performance of a venturi pump and the control of a peristaltic flow-based pump to provide a stable environment for the surgeon and patient. The user-friendly system includes a one-step, one-hand cassette, intuitive touch screen, and intelligent help feature.

For more information, visit AMO at Booths 941 and 1241.

Related Videos
Paul Badawi, co-founder and CEO of Sight Sciences, chats with Neda Shamie, MD, about what drives him
© 2024 MJH Life Sciences

All rights reserved.